Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells
出版年份 2016 全文链接
标题
Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells
作者
关键词
Proteasome pathway, Velcade<sup>®</sup>, SKP2, p27Kip1, Apoptosis
出版物
Journal of Translational Medicine
Volume 14, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-03-09
DOI
10.1186/s12967-016-0823-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2
- (2015) Azfar Jamal et al. CELL CYCLE
- Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model
- (2015) Kodappully Sivaraman Siveen et al. Oncotarget
- E3-ligase Skp2 predicts poor prognosis and maintains cancer stem cell pool in nasopharyngeal carcinoma
- (2015) Jing Wang et al. Oncotarget
- The ubiquitin proteasome system — Implications for cell cycle control and the targeted treatment of cancer
- (2013) Florian Bassermann et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential
- (2013) Yu-Feng Tian et al. TUMOR BIOLOGY
- The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis
- (2012) Chia-Hsin Chan et al. CELL
- Apigenin induces apoptosisviadownregulation of S-phase kinase-associated protein 2-mediated induction of p27Kip1 in primary effusion lymphoma cells
- (2010) A. R. Hussain et al. CELL PROLIFERATION
- Skp2 knockout reduces cell proliferation and mouse body size: and prevents cancer?
- (2010) Liang Zhu CELL RESEARCH
- Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targets
- (2010) Lynn Bedford et al. NATURE REVIEWS DRUG DISCOVERY
- Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer
- (2009) Shahab Uddin et al. LABORATORY INVESTIGATION
- Proteasome inhibitor MG-132 mediated expression of p27Kip1 via S-phase kinase protein 2 degradation induces cell cycle coupled apoptosis in primary effusion lymphoma cells
- (2009) Azhar R. Hussain et al. LEUKEMIA & LYMPHOMA
- Imatinib Mesylate Induces Quiescence in Gastrointestinal Stromal Tumor Cells through the CDH1-SKP2-p27Kip1Signaling Axis
- (2008) Ying Liu et al. CANCER RESEARCH
- Bortezomib (Velcade) Induces p27Kip1 Expression through S-Phase Kinase Protein 2 Degradation in Colorectal Cancer
- (2008) S. Uddin et al. CANCER RESEARCH
- S-phase kinase protein 2 is an attractive therapeutic target in a subset of diffuse large B-cell lymphoma
- (2008) S Uddin et al. JOURNAL OF PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search